Filtered By:
Drug: Aspirin
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 3663 results found since Jan 2013.
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
CONCLUSION: Aspirin did not prevent CV events, with a significantly increased risk of minor bleeding and renal events. Besides, aspirin use had no statistically significant reduction in the risk of all-cause mortality but had a statistically significant reduction in the risk of CV mortality.PMID:37259222 | DOI:10.2174/1570161121666230530154647
Source: Current Vascular Pharmacology - June 1, 2023 Category: Drugs & Pharmacology Authors: Ting Chen Yunlei Deng Rong Gong Source Type: research
Comprehensive Review of Hypertensive Disorders Related to Pregnancy
South Med J. 2023 Jun;116(6):482-489. doi: 10.14423/SMJ.0000000000001571.ABSTRACTHypertensive disorder of pregnancy is a common complication during pregnancy that affects approximately 10% of pregnancies and is responsible for nearly 14% of maternal deaths worldwide. It affects the mother and the fetus simultaneously, sometimes putting the health of the mother and the fetus at odds with each other. It may present with only hypertension and proteinuria or with life-threatening complications in the mother such as eclampsia; stroke; acute pulmonary edema; acute renal failure; disseminated intravascular coagulation; placental ...
Source: Southern Medical Journal - June 1, 2023 Category: General Medicine Authors: Eera Fatima Bangi Muhammad Hamza Yousuf Shubekshya Upadhyay Pranjal Jain Rohit Jain Source Type: research
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
CONCLUSION: Aspirin did not prevent CV events, with a significantly increased risk of minor bleeding and renal events. Besides, aspirin use had no statistically significant reduction in the risk of all-cause mortality but had a statistically significant reduction in the risk of CV mortality.PMID:37259222 | DOI:10.2174/1570161121666230530154647
Source: Current Vascular Pharmacology - June 1, 2023 Category: Drugs & Pharmacology Authors: Ting Chen Yunlei Deng Rong Gong Source Type: research
Comprehensive Review of Hypertensive Disorders Related to Pregnancy
South Med J. 2023 Jun;116(6):482-489. doi: 10.14423/SMJ.0000000000001571.ABSTRACTHypertensive disorder of pregnancy is a common complication during pregnancy that affects approximately 10% of pregnancies and is responsible for nearly 14% of maternal deaths worldwide. It affects the mother and the fetus simultaneously, sometimes putting the health of the mother and the fetus at odds with each other. It may present with only hypertension and proteinuria or with life-threatening complications in the mother such as eclampsia; stroke; acute pulmonary edema; acute renal failure; disseminated intravascular coagulation; placental ...
Source: Southern Medical Journal - June 1, 2023 Category: General Medicine Authors: Eera Fatima Bangi Muhammad Hamza Yousuf Shubekshya Upadhyay Pranjal Jain Rohit Jain Source Type: research
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
CONCLUSION: Aspirin did not prevent CV events, with a significantly increased risk of minor bleeding and renal events. Besides, aspirin use had no statistically significant reduction in the risk of all-cause mortality but had a statistically significant reduction in the risk of CV mortality.PMID:37259222 | DOI:10.2174/1570161121666230530154647
Source: Current Vascular Pharmacology - June 1, 2023 Category: Drugs & Pharmacology Authors: Ting Chen Yunlei Deng Rong Gong Source Type: research
Comprehensive Review of Hypertensive Disorders Related to Pregnancy
South Med J. 2023 Jun;116(6):482-489. doi: 10.14423/SMJ.0000000000001571.ABSTRACTHypertensive disorder of pregnancy is a common complication during pregnancy that affects approximately 10% of pregnancies and is responsible for nearly 14% of maternal deaths worldwide. It affects the mother and the fetus simultaneously, sometimes putting the health of the mother and the fetus at odds with each other. It may present with only hypertension and proteinuria or with life-threatening complications in the mother such as eclampsia; stroke; acute pulmonary edema; acute renal failure; disseminated intravascular coagulation; placental ...
Source: Southern Medical Journal - June 1, 2023 Category: General Medicine Authors: Eera Fatima Bangi Muhammad Hamza Yousuf Shubekshya Upadhyay Pranjal Jain Rohit Jain Source Type: research
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
CONCLUSION: Aspirin did not prevent CV events, with a significantly increased risk of minor bleeding and renal events. Besides, aspirin use had no statistically significant reduction in the risk of all-cause mortality but had a statistically significant reduction in the risk of CV mortality.PMID:37259222 | DOI:10.2174/1570161121666230530154647
Source: Current Vascular Pharmacology - June 1, 2023 Category: Drugs & Pharmacology Authors: Ting Chen Yunlei Deng Rong Gong Source Type: research
Comprehensive Review of Hypertensive Disorders Related to Pregnancy
South Med J. 2023 Jun;116(6):482-489. doi: 10.14423/SMJ.0000000000001571.ABSTRACTHypertensive disorder of pregnancy is a common complication during pregnancy that affects approximately 10% of pregnancies and is responsible for nearly 14% of maternal deaths worldwide. It affects the mother and the fetus simultaneously, sometimes putting the health of the mother and the fetus at odds with each other. It may present with only hypertension and proteinuria or with life-threatening complications in the mother such as eclampsia; stroke; acute pulmonary edema; acute renal failure; disseminated intravascular coagulation; placental ...
Source: Southern Medical Journal - June 1, 2023 Category: General Medicine Authors: Eera Fatima Bangi Muhammad Hamza Yousuf Shubekshya Upadhyay Pranjal Jain Rohit Jain Source Type: research
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
CONCLUSION: Aspirin did not prevent CV events, with a significantly increased risk of minor bleeding and renal events. Besides, aspirin use had no statistically significant reduction in the risk of all-cause mortality but had a statistically significant reduction in the risk of CV mortality.PMID:37259222 | DOI:10.2174/1570161121666230530154647
Source: Current Vascular Pharmacology - June 1, 2023 Category: Drugs & Pharmacology Authors: Ting Chen Yunlei Deng Rong Gong Source Type: research
Comprehensive Review of Hypertensive Disorders Related to Pregnancy
South Med J. 2023 Jun;116(6):482-489. doi: 10.14423/SMJ.0000000000001571.ABSTRACTHypertensive disorder of pregnancy is a common complication during pregnancy that affects approximately 10% of pregnancies and is responsible for nearly 14% of maternal deaths worldwide. It affects the mother and the fetus simultaneously, sometimes putting the health of the mother and the fetus at odds with each other. It may present with only hypertension and proteinuria or with life-threatening complications in the mother such as eclampsia; stroke; acute pulmonary edema; acute renal failure; disseminated intravascular coagulation; placental ...
Source: Southern Medical Journal - June 1, 2023 Category: General Medicine Authors: Eera Fatima Bangi Muhammad Hamza Yousuf Shubekshya Upadhyay Pranjal Jain Rohit Jain Source Type: research
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
CONCLUSION: Aspirin did not prevent CV events, with a significantly increased risk of minor bleeding and renal events. Besides, aspirin use had no statistically significant reduction in the risk of all-cause mortality but had a statistically significant reduction in the risk of CV mortality.PMID:37259222 | DOI:10.2174/1570161121666230530154647
Source: Current Vascular Pharmacology - June 1, 2023 Category: Drugs & Pharmacology Authors: Ting Chen Yunlei Deng Rong Gong Source Type: research
